213 related articles for article (PubMed ID: 37887559)
1. Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression.
Jahangiri L
Curr Oncol; 2023 Oct; 30(10):9116-9140. PubMed ID: 37887559
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.
Hochheuser C; Windt LJ; Kunze NY; de Vos DL; Tytgat GAM; Voermans C; Timmerman I
Stem Cells Dev; 2021 Jan; 30(2):59-78. PubMed ID: 33287630
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.
Braekeveldt N; Wigerup C; Tadeo I; Beckman S; Sandén C; Jönsson J; Erjefält JS; Berbegall AP; Börjesson A; Backman T; Øra I; Navarro S; Noguera R; Gisselsson D; Påhlman S; Bexell D
Cancer Lett; 2016 Jun; 375(2):384-389. PubMed ID: 27000989
[TBL] [Abstract][Full Text] [Related]
4. Verification of genetic differences and immune cell infiltration subtypes in the neuroblastoma tumour microenvironment during immunotherapy.
Qian B; Sun J; Zuo P; Da M; Mo X; Fang Y
World J Surg Oncol; 2022 May; 20(1):169. PubMed ID: 35643506
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in Neuroblastoma Biology, Diagnosis, and Treatment.
Jahangiri L; Ishola T
Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362869
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
7. The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.
Horwacik I
Cells; 2022 Oct; 11(19):. PubMed ID: 36231134
[TBL] [Abstract][Full Text] [Related]
8. Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets.
Yang Y; Li H; Zheng D; Li X; Liu H
Aging (Albany NY); 2023 Nov; 15(22):13345-13367. PubMed ID: 38019470
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia in the Initiation and Progression of Neuroblastoma Tumours.
Huertas-Castaño C; Gómez-Muñoz MA; Pardal R; Vega FM
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861671
[TBL] [Abstract][Full Text] [Related]
10. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
11. More than the genes, the tumor microenvironment in neuroblastoma.
Borriello L; Seeger RC; Asgharzadeh S; DeClerck YA
Cancer Lett; 2016 Sep; 380(1):304-14. PubMed ID: 26597947
[TBL] [Abstract][Full Text] [Related]
12. The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma.
Marimpietri D; Airoldi I; Faini AC; Malavasi F; Morandi F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921337
[TBL] [Abstract][Full Text] [Related]
13. Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Rivera Z; Escutia C; Madonna MB; Gupta KH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239815
[TBL] [Abstract][Full Text] [Related]
14. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets.
Coronado E; Yañez Y; Vidal E; Rubio L; Vera-Sempere F; Cañada-Martínez AJ; Panadero J; Cañete A; Ladenstein R; Castel V; Font de Mora J
Mol Oncol; 2021 Feb; 15(2):364-380. PubMed ID: 33252831
[TBL] [Abstract][Full Text] [Related]
16. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
[TBL] [Abstract][Full Text] [Related]
17. Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination.
Truong DQ; Ho BT; Chau GC; Truong DK; Pham TTT; Nakagawara A; Bui CB
Pediatr Dev Pathol; 2022; 25(2):91-98. PubMed ID: 34460335
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma.
Maris JM; Hogarty MD; Bagatell R; Cohn SL
Lancet; 2007 Jun; 369(9579):2106-20. PubMed ID: 17586306
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.
Costa A; Thirant C; Kramdi A; Pierre-Eugène C; Louis-Brennetot C; Blanchard O; Surdez D; Gruel N; Lapouble E; Pierron G; Sitbon D; Brisse H; Gauthier A; Fréneaux P; Bohec M; Raynal V; Baulande S; Leclere R; Champenois G; Nicolas A; Meseure D; Bellini A; Marabelle A; Geoerger B; Mechta-Grigoriou F; Schleiermacher G; Menger L; Delattre O; Janoueix-Lerosey I
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36054452
[TBL] [Abstract][Full Text] [Related]
20. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
